Assessing Moral Cognitive Skills in Adults With Autism Spectrum Disorders
CoMorA
1 other identifier
interventional
60
1 country
1
Brief Summary
In the international literature, it is currently accepted that, relative to neurotypicals, people with Autism Spectrum Disorder (ASD) present patterns of moral judgments marked by a minimization of intentionality and a strong condemnation of agents responsible for accidents. However, until now, all studies are based on declarative paradigms, and no one has proposed to examine the relationship of people with ASD to moral transgressions (i.e. to a bad action done deliberately or to a good deed deliberately omitted) in an implicit paradigm, that is, when the answer is made on the assignment of an expressive face to these moral offenses. Furthermore, no study has investigated whether diminished sensitivity to intention and intransigence of incidental judgment occur in both automatic (implicit) and deliberative (explicit) settings. Investigators planned to study how people with ASD without intellectual disability process emotions expressed by others in response to different forms of moral offense and to examine whether patterns potentially contrast in degree and/or kind with those of neurotypicals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedStudy Start
First participant enrolled
May 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedMarch 7, 2024
March 1, 2024
1.9 years
July 19, 2022
March 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evaluation of moral cognition
First the reading of a vignette presenting a moral scenario jointly manipulating variables of intention and consequence. This systematic manipulation, commonly used in the field of moral judgment, leads to 4 combinations of variables: intentional harm: present intention; present consequence attempted harm: present intention; absent consequence accidental harm: absent intention; present consequence accidental harm with positive intention: positive intention; present consequence A presentation to the participants of a face presenting an intense facial expression (in a counterbalanced way of man or woman. Explicit procedure: After the implicit classification task, the participants will see the same photo and will have to indicate whether the expression of this person is appropriate to the situation described. The proportion of correct answers (CP) will be recorded.
at day 0
Evaluation of moral cognition
First the reading of a vignette presenting a moral scenario jointly manipulating variables of intention and consequence. This systematic manipulation, commonly used in the field of moral judgment, leads to 4 combinations of variables: intentional harm: present intention; present consequence attempted harm: present intention; absent consequence accidental harm: absent intention; present consequence accidental harm with positive intention: positive intention; present consequence A presentation to the participants of a face presenting an intense facial expression (in a counterbalanced way of man or woman 1\. Implicit procedure: The participants will participate to an implicit task consisting in classifying as quickly as possible the sex to which the character of the photograph belongs (male or female). The response time (TR) will be recorded.
between day 1 and day 21
Secondary Outcomes (4)
Reasoning and general intellectual level
at day 0 and between day 1 and day 21
Attentional and executive measures
at day 0 and between day 1 and day 21
Social cognitive measures
at day 0 and between day 1 and day 21
Alexithymia
at day 0 and between day 1 and day 21
Study Arms (2)
People with ASD
EXPERIMENTAL30 people with ASD without IDD
Neurotypicals
ACTIVE COMPARATOR30 neurotypicals
Interventions
Day 0: sending of the information notice Day 1 : signing the consent form + neuropsychological tests assessing reasoning and abstraction abilities, attentional processes, executive functions (including inhibition and mental flexibility) and social cognitive functions, including facial emotion recognition, theory of mind and perception and social knowledge (duration 1h30-2h). Experimental protocol: vignettes of moral offenses manipulating variables of intention and consequence. This systematic manipulation, commonly used in the field of moral judgment, usually leads to 3 combinations of variables: intentional harm (present intention; present consequence); attempted harm (intent present; consequence absent); accidental harm (intention absent; consequence present). Another form of accidental harm will also be constructed (positive intention; present consequence) (duration : 1h) Between day 1 and day 21 : second part of the Day 1 tests
Eligibility Criteria
You may qualify if:
- ASD group:
- Diagnosis of ASD according to DSM-5 criteria
- Age between 18 and 40 years old
- Francophone
- Affiliated to social security
- Having given their consent to participate in the study
- Patient under guardianship and curatorship
- Neurotypical group:
- Age between 18 and 40 years old
- Francophone
- Affiliated to a social security scheme
- Having given their consent to participate in the study
You may not qualify if:
- ASD group:
- Diagnosis of intellectual development disorder established according to DSM-5 criteria
- Language, sensory or motor impairments hindering participation in the study
- Control group:
- Neurodevelopmental pathology (declarative)
- Neurological pathology
- Language, sensory or motor impairments hindering participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
centre de réhabilitation - Hôpital le Vinatier
Lyon, Rhône, 69006, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elodie PEYROUX
Centre Hospitalier le Vinatier
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2022
First Posted
September 22, 2022
Study Start
May 2, 2023
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
March 7, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share